Post-listing view of Entero Healthcare Solutions from Shivani Nyati, Head of Wealth, Swastika Investmart

Entero Healthcare Solutions Ltd.'s initial public offering (IPO) witnessed a negative debut, listing at Rs 1228 per share, a 2.33% decline from its issue price of Rs 1258. This underwhelming performance fell short of pre-listing expectations and highlighted certain concerns surrounding the company's financial health.

Entero has incurred losses in the past three fiscal years, raising concerns about its financial sustainability and profitability. It also faces challenges with negative cash flows from all three major activities, impacting working capital requirements.

While Entero possesses certain strengths, its financial situation calls for a cautious approach, and this stock is best avoided by new investors. Even investors who got allotments through IPO are advised to exit their holdings.